Clinical Trial Update: Clinical Evaluation of GENEX® DS in Instrumented Posterolateral Fusion

View source ↗

Summary

A clinical trial evaluating GENEX DS for instrumented posterolateral fusion has been terminated, with limited publicly available results in the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Disc Disease
• Spinal Stenosis
• Spondylolisthesis

Drugs mentioned

• GENEX DS

Snippet

Sponsor: Spine Wave | Conditions: Degenerative Disc Disease, Spondylolisthesis | Status: TERMINATED